EMA to launch consultation on clinical aspects specific to TEPs
This article was originally published in Clinica
Executive Summary
The European Medicines Agency's Committee for Advanced Therapies (CAT), which oversees the regulation of gene, cell and tissue therapy products, is soon to release its reflection paper on clinical aspects specific to tissue-engineered products (TEPs) for external consultation .